Risk factors for chemotherapy ‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy

ConclusionThis study confirmed the CIPN risk related to certain variables and identified new ones. This knowledge can assist with treatment decisions and patient education.

Source: Brain and Behavior - May 6, 2019 Category: Neurology Authors: Alex Molassiotis, Hui Lin Cheng, Kwun To Leung, Yu Chung Li, Kam Hung Wong, Joseph Siu Kie Au, Raghav Sundar, Alexandre Chan, Terrence Rong De Ng, Lorna K. P. Suen, Choi Wan Chan, Janelle Yorke, Violeta Lopez Tags: ORIGINAL RESEARCH Source Type: research